Mostrando 10 resultados de: 52
Publisher
Pharmaceutics(5)
Biomedicine and Pharmacotherapy(4)
Journal of Nanobiotechnology(4)
International Journal of Pharmaceutics(3)
Nanomaterials(3)
Área temáticas
Farmacología y terapéutica(40)
Enfermedades(37)
Fisiología humana(17)
Medicina y salud(16)
Cirugía y especialidades médicas afines(5)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(52)
ODS 10: Reducción de las desigualdades(30)
ODS 9: Industria, innovación e infraestructura(29)
ODS 12: Producción y consumo responsables(12)
ODS 2: Hambre cero(12)
Origen
scopus(52)
A metabolic perspective of late onset Alzheimer's disease
ReviewAbstract: After decades of research, the molecular neuropathology of Alzheimer's disease (AD)is still one of tPalabras claves:Alzheimer's disease, c-Jun N-terminal kinase inhibitors, Insulin, Licochalcone A, neuroinflammation, Reticulum stress, Type 2 Diabetes mellitusAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Verdaguer E., Zárate C.B.Fuentes:scopusA novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
ArticleAbstract: Background: Alzheimer’s disease (AD) is characterized by a polyetiological origin. Despite the globaPalabras claves:Alzheimer's disease, BACE1, BDNF, cognitive decline, dendritic spines, high-fat diet, neuroinflammation, Rhein-huprine hybrid, Tau, TLR4Autores:Antoni Camins, Auladell C., Bulló M., Cano A., Espinosa-Jimenez T., Ettcheto M., Folch J., Muñoz-Torrero D., Olloquequi J., Parcerisas A., Pont C., Sanchez-Lopez E., Verdaguer E.Fuentes:scopusADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
ReviewAbstract: Alzheimer's disease (AD) represents a global burden in the economics of healthcare systems. Amyloid-Palabras claves:ADAM10, Alzheimer's disease, Natural compounds, Pharmaceutical, α-SecretaseAutores:Antoni Camins, Busquets O., Cano A., Cominetti M.R., Di Luca M., Endres K., Ettcheto M., Manzine P.R., Marcello E., Olloquequi J., Pelucchi S.Fuentes:scopusThe preclinical discovery and development of opicapone for the treatment of Parkinson’s disease
ArticleAbstract: Introduction: Opicapone (OPC) is a well-established catechol-O-methyltransferase (COMT) inhibitor thPalabras claves:dyskinesia, entacapone, Opicapone, Parkinson's Disease, tolcaponeAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Verdaguer E.Fuentes:scopusState of the art on toxicological mechanisms of metal and metal oxide nanoparticles and strategies to reduce toxicological risks
ReviewAbstract: Metal nanoparticles have been extensively investigated for different types of pharmaceutical applicaPalabras claves:Metal nanoparticles, Nanoparticles functionalization, Nanoparticles toxicity, Reactive oxygen speciesAutores:Antoni Camins, Barroso E., Cano A., Espina M., Ettcheto M., García M.L., García-Torra V., Sanchez-Lopez E., Souto E.M.B., Vázquez-Carrera M.Fuentes:scopusState-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
ReviewAbstract: Infectious diseases kill over 17 million people a year, among which bacterial infections stand out.Palabras claves:Bacterial Infections, Infectious diseases, nanomedicine, nanotechnology, Polymeric nanoparticlesAutores:Antoni Camins, Cajal Y., Cano A., Espina M., Ettcheto M., García M.L., Lopez-Machado A.L., Rabanal F., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusSurface functionalization of plga nanoparticles to increase transport across the bbb for alzheimer’s disease
ReviewAbstract: Alzheimer’s disease (AD) is a chronic neurodegenerative disorder that accounts for about 60% of allPalabras claves:Alzheimer's disease, blood-brain barrier, Brain delivery, Functionalized PLGA nanoparticlesAutores:Amo L.D., Antoni Camins, Cano A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusThe Ethyl Acetate Extract of Leaves of Ugni molinae Turcz. Improves Neuropathological Hallmarks of Alzheimer's Disease in Female APPswe/PS1dE9 Mice Fed with a High Fat Diet
ArticleAbstract: The most common type of dementia is Alzheimer's disease (AD), a progressive neurodegenerative diseasPalabras claves:APPswe/PS1dE9, ethyl acetate extract, high-fat diet, hippocampus, neuroinflammation, Ugni molinaeAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Castro-Torres R.D., Delporte C., Ettcheto M., Folch J., Jara-Moreno D., Kogan M.J., Verdaguer E.Fuentes:scopusThe Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
ReviewAbstract: Nowadays, Alzheimer’s disease (AD) is a severe sociological and clinical problem. Since it was firstPalabras claves:Alzheimer's disease, Insulin Resistance, Mediterranean diet, neuroinflammation and neurodegeneration, obesity, Type 2 Diabetes mellitusAutores:Antoni Camins, Auladell C., Bulló M., Busquets O., Cano A., Casadesús G., Espinosa-Jimenez T., Ettcheto M., Folch J., García M.L., Olloquequi J., Sanchez-Lopez E., Zárate C.B.Fuentes:scopusBenzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
ArticleAbstract: Benzodiazepines (BZDs) and Z-drugs are compounds widely prescribed in medical practice due to theirPalabras claves:Alzheimer's disease, benzodiazepines, COGNITION, dementia, Risk FactorsAutores:Antoni Camins, Auladell C., Bulló M., Busquets O., Cano A., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Zárate C.B.Fuentes:scopus